According to laboratory assessment, tumor PD-L1 expression data were available for 38 patients; of these, 11 (27.5%) patients had a PD-L1 TPS of ≥ 1%, and 5 (12.5%) patients had a PD-L1 TPS of ≥ 50%. The gene discussed is CD274; the disease is neoplasm.